LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients

by in

LivaNova has received CE Mark approval for its Bicarbon® aortic valves for use with low-dose anticoagulant therapy.